Skip to content

Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients

Interleukin-6, Procalcitonin and Vascular Endothelial Growth Factor in Plasma and Dialysate Correlate With Peritoneal Solute Transport and Dialysis Adequacy in CAPD Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02881892
Enrollment
26
Registered
2016-08-29
Start date
2012-03-31
Completion date
2014-06-30
Last updated
2016-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

CAPD, Peritoneal solute transport rate, Dialysis adequacy

Brief summary

The aim of study was to evaluated the correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.

Detailed description

This cross -sectional study measured IL-6, procalcitonin and VEGF level in plasma and overnight effluent. PSTR of small solutes was evaluated by standard peritoneal equilibration test (standard PET). Weekly Kt/V and creatinine clearance (CCr ) were evaluated in all patients.

Interventions

OTHERMeasure plasma and dialysate level of IL-6, procalcitonin and VEGF

correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.

Sponsors

Bangkok Metropolitan Administration Medical College and Vajira Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Stable CAPD patients without previous history of peritonitis

Exclusion criteria

* HIV * Other infections, tuberculosis or on immunosuppressive drugs, * Autoimmune disease, * Cancer * Diagnosis of permanent ultrafiltration failure .

Design outcomes

Primary

MeasureTime frameDescription
plasma level of VEGF, IL-6 and procalcitonin with the PSTR and dialysis adequacy in CAPD patients2 yearsmeasure in pg/ml

Secondary

MeasureTime frameDescription
Cytokines in diabetic and non-diabetic group2 yearsAll cytokines in plasma and blood

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026